K083445 is an FDA 510(k) clearance for the N ANTISERA TO HUMAN IMMUNOGLOBULINS (IGG, IGA AND IGM) AND N/T PROTEIN CONTROL LC. This device is classified as a Method, Nephelometric, Immunoglobulins (g, A, M) (Class II - Special Controls, product code CFN).
Submitted by Siemens Healthcare Diagnostics (Newark, US). The FDA issued a Cleared decision on March 24, 2009, 123 days after receiving the submission on November 21, 2008.
This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5510.